HEADER SIGNALING PROTEIN 07-JUN-18 6GQM TITLE CRYSTAL STRUCTURE OF HUMAN C-KIT KINASE DOMAIN IN COMPLEX WITH A SMALL TITLE 2 MOLECULE INHIBITOR, AZD3229 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO-ONCOGENE C-KIT, COMPND 5 TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY-ZUCKERMAN 4 FELINE COMPND 6 SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: HUMAN C-KIT KINASE DOMAIN (P551-H934) BEARING SURFACE COMPND 11 MUTATIONS TO OPTIMISE PROTEIN EXPRESSION (I563S, V569S, Y609Q, L631S, COMPND 12 M651E, I662H, D768H, R804N, V825D, C844S, L890S, H894Y, L912D, COMPND 13 L923D), AND THE KINASE INSERT DOMAIN(S688-D765) DELETED AND REPLACED COMPND 14 WITH THE SEQUENCE EFVPYKVAPEDLYKDFLT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, ONCOLOGY, GASTROINTESTINAL KEYWDS 2 STROMAL TUMOUR, STRUCTURE-BASED DRUG DESIGN, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,C.J.HARDY,D.J.OGG,R.C.OVERMAN,M.J.PACKER,J.G.KETTLE, AUTHOR 2 R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,A.CAMPBELL,K.GOLDBERG,M.GRONDINE, AUTHOR 3 S.GUICHARD,T.HUNT,O.JONES,X.LI,O.MOLEVA,S.PEARSON,W.SHAO,A.SMITH, AUTHOR 4 J.SMITH,D.STEAD,S.STOKES,M.TUCKER,Y.YE REVDAT 3 31-OCT-18 6GQM 1 JRNL REVDAT 2 03-OCT-18 6GQM 1 JRNL REVDAT 1 19-SEP-18 6GQM 0 JRNL AUTH J.G.KETTLE,R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,S.BOYD, JRNL AUTH 2 A.CAMPBELL,K.GOLDBERG,M.GRONDINE,S.GUICHARD,C.J.HARDY, JRNL AUTH 3 T.HUNT,R.D.O.JONES,X.LI,O.MOLEVA,D.OGG,R.C.OVERMAN, JRNL AUTH 4 M.J.PACKER,S.PEARSON,M.SCHIMPL,W.SHAO,A.SMITH,J.M.SMITH, JRNL AUTH 5 D.STEAD,S.STOKES,M.TUCKER,Y.YE JRNL TITL DISCOVERY OF JRNL TITL 2 N-(4-{[5-FLUORO-7-(2-METHOXYETHOXY) JRNL TITL 3 QUINAZOLIN-4-YL]AMINO}PHENYL)-2-[4-(PROPAN-2-YL)-1 JRNL TITL 4 H-1,2,3-TRIAZOL-1-YL]ACETAMIDE (AZD3229), A POTENT PAN-KIT JRNL TITL 5 MUTANT INHIBITOR FOR THE TREATMENT OF GASTROINTESTINAL JRNL TITL 6 STROMAL TUMORS. JRNL REF J. MED. CHEM. V. 61 8797 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30204441 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00938 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 49595 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2479 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.05 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.67 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3602 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2410 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3422 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 180 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.56000 REMARK 3 B22 (A**2) : 2.92800 REMARK 3 B33 (A**2) : 4.63200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.170 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.146 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.145 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4811 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6508 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1646 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 102 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 692 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4811 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 605 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5679 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.99 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 27.0522 97.3938 15.8022 REMARK 3 T TENSOR REMARK 3 T11: 0.1280 T22: 0.1651 REMARK 3 T33: 0.0331 T12: -0.0328 REMARK 3 T13: -0.0212 T23: -0.0094 REMARK 3 L TENSOR REMARK 3 L11: 0.9206 L22: 1.5986 REMARK 3 L33: 2.3845 L12: 0.1494 REMARK 3 L13: -0.5453 L23: -0.5523 REMARK 3 S TENSOR REMARK 3 S11: -0.0046 S12: 0.0010 S13: -0.0420 REMARK 3 S21: -0.0053 S22: 0.0020 S23: -0.0232 REMARK 3 S31: 0.0676 S32: 0.0007 S33: 0.0025 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 63.6783 90.7366 20.7026 REMARK 3 T TENSOR REMARK 3 T11: 0.2504 T22: 0.2465 REMARK 3 T33: 0.2061 T12: -0.0329 REMARK 3 T13: -0.0225 T23: 0.0083 REMARK 3 L TENSOR REMARK 3 L11: 1.3499 L22: 6.2232 REMARK 3 L33: 1.2122 L12: -0.8760 REMARK 3 L13: -0.0648 L23: 0.2127 REMARK 3 S TENSOR REMARK 3 S11: 0.0003 S12: 0.0245 S13: 0.2267 REMARK 3 S21: -0.2701 S22: -0.0132 S23: 0.2597 REMARK 3 S31: -0.2559 S32: 0.0987 S33: 0.0129 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GQM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98007 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49740 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 45.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.25800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9 % PEG 8000, 18 % ETHYLENE GLYCOL, REMARK 280 0.1 M PCTP PH 6.2, 0.03 M SODIUM FLUORIDE, 0.03 M SODIUM BROMIDE, REMARK 280 0.03 M SODIUM IODIDE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.98500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.57500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.09000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.57500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.98500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.09000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 547 REMARK 465 SER A 548 REMARK 465 HIS A 549 REMARK 465 MET A 550 REMARK 465 PRO A 551 REMARK 465 MET A 552 REMARK 465 TYR A 553 REMARK 465 GLU A 554 REMARK 465 VAL A 555 REMARK 465 GLN A 556 REMARK 465 TRP A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 VAL A 560 REMARK 465 GLU A 561 REMARK 465 GLU A 562 REMARK 465 SER A 563 REMARK 465 ASN A 564 REMARK 465 GLY A 565 REMARK 465 ASN A 566 REMARK 465 ASN A 567 REMARK 465 TYR A 568 REMARK 465 LYS A 753 REMARK 465 VAL A 754 REMARK 465 ALA A 755 REMARK 465 PRO A 756 REMARK 465 GLU A 757 REMARK 465 ASP A 758 REMARK 465 THR A 932 REMARK 465 ASN A 933 REMARK 465 HIS A 934 REMARK 465 GLY B 547 REMARK 465 SER B 548 REMARK 465 HIS B 549 REMARK 465 MET B 550 REMARK 465 PRO B 551 REMARK 465 MET B 552 REMARK 465 TYR B 553 REMARK 465 GLU B 554 REMARK 465 VAL B 555 REMARK 465 GLN B 556 REMARK 465 TRP B 557 REMARK 465 LYS B 558 REMARK 465 VAL B 559 REMARK 465 VAL B 560 REMARK 465 GLU B 561 REMARK 465 GLU B 562 REMARK 465 SER B 563 REMARK 465 ASN B 564 REMARK 465 GLY B 565 REMARK 465 ASN B 566 REMARK 465 ASN B 567 REMARK 465 TYR B 568 REMARK 465 SER B 569 REMARK 465 TYR B 570 REMARK 465 ILE B 571 REMARK 465 ASP B 572 REMARK 465 PRO B 573 REMARK 465 THR B 574 REMARK 465 GLN B 575 REMARK 465 LEU B 576 REMARK 465 VAL B 754 REMARK 465 ALA B 755 REMARK 465 PRO B 756 REMARK 465 GLU B 757 REMARK 465 ASP B 758 REMARK 465 LEU B 759 REMARK 465 TYR B 760 REMARK 465 THR B 932 REMARK 465 ASN B 933 REMARK 465 HIS B 934 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 613 CG CD CE NZ REMARK 470 TYR A 692 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 HIS A 802 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 885 CG CD OE1 OE2 REMARK 470 HIS B 580 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 634 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 693 CG CD CE NZ REMARK 470 LYS B 761 CG CD CE NZ REMARK 470 ASP B 762 CG OD1 OD2 REMARK 470 PHE B 763 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 791 -17.33 77.27 REMARK 500 THR A 801 -163.28 -125.08 REMARK 500 HIS B 580 -7.81 -59.96 REMARK 500 ARG B 791 -15.84 77.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1275 DISTANCE = 5.83 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F8H A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F8H B 1001 DBREF 6GQM A 551 934 UNP P10721 KIT_HUMAN 551 934 DBREF 6GQM B 551 934 UNP P10721 KIT_HUMAN 551 934 SEQADV 6GQM GLY A 547 UNP P10721 EXPRESSION TAG SEQADV 6GQM SER A 548 UNP P10721 EXPRESSION TAG SEQADV 6GQM HIS A 549 UNP P10721 EXPRESSION TAG SEQADV 6GQM MET A 550 UNP P10721 EXPRESSION TAG SEQADV 6GQM SER A 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 6GQM SER A 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 6GQM GLN A 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 6GQM SER A 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 6GQM GLU A 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 6GQM HIS A 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 6GQM GLU A 688 UNP P10721 SER 688 CONFLICT SEQADV 6GQM VAL A 690 UNP P10721 ILE 690 CONFLICT SEQADV 6GQM PRO A 691 UNP P10721 CYS 691 CONFLICT SEQADV 6GQM TYR A 692 UNP P10721 SER 692 CONFLICT SEQADV 6GQM VAL A 754 UNP P10721 ALA 755 CONFLICT SEQADV 6GQM ALA A 755 UNP P10721 ILE 756 CONFLICT SEQADV 6GQM PRO A 756 UNP P10721 MET 757 CONFLICT SEQADV 6GQM LEU A 759 UNP P10721 INSERTION SEQADV 6GQM TYR A 760 UNP P10721 ASP 760 CONFLICT SEQADV 6GQM LYS A 761 UNP P10721 GLU 761 CONFLICT SEQADV 6GQM ASP A 762 UNP P10721 LEU 762 CONFLICT SEQADV 6GQM PHE A 763 UNP P10721 ALA 763 CONFLICT SEQADV 6GQM THR A 765 UNP P10721 ASP 765 CONFLICT SEQADV 6GQM HIS A 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 6GQM ASN A 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 6GQM ASP A 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 6GQM SER A 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 6GQM SER A 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 6GQM TYR A 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 6GQM ASP A 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 6GQM ASP A 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQADV 6GQM GLY B 547 UNP P10721 EXPRESSION TAG SEQADV 6GQM SER B 548 UNP P10721 EXPRESSION TAG SEQADV 6GQM HIS B 549 UNP P10721 EXPRESSION TAG SEQADV 6GQM MET B 550 UNP P10721 EXPRESSION TAG SEQADV 6GQM SER B 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 6GQM SER B 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 6GQM GLN B 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 6GQM SER B 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 6GQM GLU B 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 6GQM HIS B 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 6GQM GLU B 688 UNP P10721 SER 688 CONFLICT SEQADV 6GQM VAL B 690 UNP P10721 ILE 690 CONFLICT SEQADV 6GQM PRO B 691 UNP P10721 CYS 691 CONFLICT SEQADV 6GQM TYR B 692 UNP P10721 SER 692 CONFLICT SEQADV 6GQM VAL B 754 UNP P10721 ALA 755 CONFLICT SEQADV 6GQM ALA B 755 UNP P10721 ILE 756 CONFLICT SEQADV 6GQM PRO B 756 UNP P10721 MET 757 CONFLICT SEQADV 6GQM LEU B 759 UNP P10721 INSERTION SEQADV 6GQM TYR B 760 UNP P10721 ASP 760 CONFLICT SEQADV 6GQM LYS B 761 UNP P10721 GLU 761 CONFLICT SEQADV 6GQM ASP B 762 UNP P10721 LEU 762 CONFLICT SEQADV 6GQM PHE B 763 UNP P10721 ALA 763 CONFLICT SEQADV 6GQM THR B 765 UNP P10721 ASP 765 CONFLICT SEQADV 6GQM HIS B 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 6GQM ASN B 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 6GQM ASP B 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 6GQM SER B 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 6GQM SER B 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 6GQM TYR B 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 6GQM ASP B 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 6GQM ASP B 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQRES 1 A 328 GLY SER HIS MET PRO MET TYR GLU VAL GLN TRP LYS VAL SEQRES 2 A 328 VAL GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP SEQRES 3 A 328 PRO THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO SEQRES 4 A 328 ARG ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY SEQRES 5 A 328 ALA PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU SEQRES 6 A 328 ILE LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET SEQRES 7 A 328 LEU LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU SEQRES 8 A 328 MET SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS SEQRES 9 A 328 GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY SEQRES 10 A 328 GLY PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY SEQRES 11 A 328 ASP LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE SEQRES 12 A 328 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 13 A 328 PHE LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN SEQRES 14 A 328 VAL ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS SEQRES 15 A 328 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR SEQRES 16 A 328 HIS GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 17 A 328 ARG ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY SEQRES 18 A 328 ASN ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER SEQRES 19 A 328 ILE PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SEQRES 20 A 328 SER TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SEQRES 21 A 328 SER SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE SEQRES 22 A 328 TYR LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO SEQRES 23 A 328 GLU TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR SEQRES 24 A 328 CYS TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS SEQRES 25 A 328 GLN ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER SEQRES 26 A 328 THR ASN HIS SEQRES 1 B 328 GLY SER HIS MET PRO MET TYR GLU VAL GLN TRP LYS VAL SEQRES 2 B 328 VAL GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP SEQRES 3 B 328 PRO THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO SEQRES 4 B 328 ARG ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY SEQRES 5 B 328 ALA PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU SEQRES 6 B 328 ILE LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET SEQRES 7 B 328 LEU LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU SEQRES 8 B 328 MET SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS SEQRES 9 B 328 GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY SEQRES 10 B 328 GLY PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY SEQRES 11 B 328 ASP LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE SEQRES 12 B 328 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 13 B 328 PHE LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN SEQRES 14 B 328 VAL ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS SEQRES 15 B 328 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR SEQRES 16 B 328 HIS GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 17 B 328 ARG ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY SEQRES 18 B 328 ASN ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER SEQRES 19 B 328 ILE PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SEQRES 20 B 328 SER TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SEQRES 21 B 328 SER SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE SEQRES 22 B 328 TYR LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO SEQRES 23 B 328 GLU TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR SEQRES 24 B 328 CYS TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS SEQRES 25 B 328 GLN ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER SEQRES 26 B 328 THR ASN HIS HET F8H A1001 35 HET CL A1002 1 HET CL A1003 1 HET F8H B1001 35 HETNAM F8H ~{N}-[4-[[5-FLUORANYL-7-(2-METHOXYETHOXY)QUINAZOLIN-4- HETNAM 2 F8H YL]AMINO]PHENYL]-2-(4-PROPAN-2-YL-1,2,3-TRIAZOL-1-YL) HETNAM 3 F8H ETHANAMIDE HETNAM CL CHLORIDE ION FORMUL 3 F8H 2(C24 H26 F N7 O3) FORMUL 4 CL 2(CL 1-) FORMUL 7 HOH *280(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 LEU A 678 ARG A 686 1 9 HELIX 6 AA6 ASP A 687 PHE A 689 5 3 HELIX 7 AA7 THR A 765 LYS A 786 1 22 HELIX 8 AA8 ALA A 794 ARG A 796 5 3 HELIX 9 AA9 PHE A 811 ARG A 815 5 5 HELIX 10 AB1 PRO A 832 MET A 836 5 5 HELIX 11 AB2 ALA A 837 SER A 844 1 8 HELIX 12 AB3 THR A 847 SER A 864 1 18 HELIX 13 AB4 ASP A 876 GLU A 885 1 10 HELIX 14 AB5 PRO A 896 TRP A 907 1 12 HELIX 15 AB6 ASP A 910 ARG A 914 5 5 HELIX 16 AB7 THR A 916 SER A 931 1 16 HELIX 17 AB8 ASP B 579 GLU B 583 5 5 HELIX 18 AB9 PRO B 585 ASN B 587 5 3 HELIX 19 AC1 HIS B 630 GLY B 648 1 19 HELIX 20 AC2 LEU B 678 ARG B 686 1 9 HELIX 21 AC3 LEU B 766 LYS B 786 1 21 HELIX 22 AC4 ALA B 794 ARG B 796 5 3 HELIX 23 AC5 HIS B 802 ASN B 804 5 3 HELIX 24 AC6 PHE B 811 ARG B 815 5 5 HELIX 25 AC7 PRO B 832 MET B 836 5 5 HELIX 26 AC8 ALA B 837 SER B 844 1 8 HELIX 27 AC9 THR B 847 SER B 864 1 18 HELIX 28 AD1 ASP B 876 GLU B 885 1 10 HELIX 29 AD2 PRO B 896 TRP B 907 1 12 HELIX 30 AD3 ASP B 910 ARG B 914 5 5 HELIX 31 AD4 THR B 916 SER B 931 1 16 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 GLN A 609 -1 O GLU A 605 N GLY A 592 SHEET 3 AA1 5 ALA A 617 LEU A 625 -1 O MET A 618 N ALA A 608 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O THR A 670 N ALA A 621 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N LEU A 657 O ILE A 669 SHEET 1 AA2 3 GLY A 676 ASP A 677 0 SHEET 2 AA2 3 ILE A 798 THR A 801 -1 O LEU A 800 N GLY A 676 SHEET 3 AA2 3 ILE A 805 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA3 2 VAL A 824 LYS A 826 0 SHEET 2 AA3 2 ALA A 829 LEU A 831 -1 O LEU A 831 N VAL A 824 SHEET 1 AA4 5 LEU B 589 ALA B 597 0 SHEET 2 AA4 5 GLY B 601 GLN B 609 -1 O GLU B 605 N GLY B 592 SHEET 3 AA4 5 ALA B 617 LEU B 625 -1 O MET B 618 N ALA B 608 SHEET 4 AA4 5 LEU B 667 GLU B 671 -1 O THR B 670 N ALA B 621 SHEET 5 AA4 5 LEU B 656 CYS B 660 -1 N LEU B 657 O ILE B 669 SHEET 1 AA5 3 GLY B 676 ASP B 677 0 SHEET 2 AA5 3 ILE B 798 THR B 801 -1 O LEU B 800 N GLY B 676 SHEET 3 AA5 3 ILE B 805 ILE B 808 -1 O LYS B 807 N LEU B 799 SHEET 1 AA6 2 PHE B 689 VAL B 690 0 SHEET 2 AA6 2 LEU B 764 THR B 765 1 O LEU B 764 N VAL B 690 SHEET 1 AA7 2 VAL B 824 LYS B 826 0 SHEET 2 AA7 2 ALA B 829 LEU B 831 -1 O LEU B 831 N VAL B 824 SITE 1 AC1 24 LEU A 595 VAL A 603 ALA A 621 LYS A 623 SITE 2 AC1 24 GLU A 640 LEU A 644 LEU A 647 ILE A 653 SITE 3 AC1 24 VAL A 654 THR A 670 GLU A 671 TYR A 672 SITE 4 AC1 24 CYS A 673 CYS A 674 TYR A 675 GLY A 676 SITE 5 AC1 24 LEU A 799 ILE A 808 CYS A 809 ASP A 810 SITE 6 AC1 24 PHE A 811 HOH A1121 HOH A1168 HOH A1182 SITE 1 AC2 2 PRO A 627 LYS A 904 SITE 1 AC3 2 THR A 666 HOH A1134 SITE 1 AC4 23 ASP A 762 LEU B 595 VAL B 603 ALA B 621 SITE 2 AC4 23 LYS B 623 GLU B 640 LEU B 644 LEU B 647 SITE 3 AC4 23 ILE B 653 VAL B 654 THR B 670 GLU B 671 SITE 4 AC4 23 TYR B 672 CYS B 673 CYS B 674 TYR B 675 SITE 5 AC4 23 GLY B 676 LEU B 799 CYS B 809 ASP B 810 SITE 6 AC4 23 PHE B 811 HOH B1115 HOH B1131 CRYST1 87.970 90.180 91.150 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011368 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011089 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010971 0.00000